Dana Farber Cancer Institute, Boston MA; Duke Oncology Network, Durham, NC; American Society of Clinical Oncology, Alexandria, VA; Oncology Nursing Consultant, New Orleans, LA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Oncology Nursing Society, Pittsburgh, PA; and Oncology Hematology Care, Cincinnati, OH.
J Oncol Pract. 2012 Jan;8(1):2-6. doi: 10.1200/JOP.2011.000339. Epub 2011 Dec 13.
In November 2009, ASCO and the Oncology Nursing Society (ONS) jointly published a set of 31 voluntary chemotherapy safety standards for adult patients with cancer, as the end result of a highly structured, multistakeholder process. The standards were explicitly created to address patient safety in the administration of parenteral and oral chemotherapeutic agents in outpatient oncology settings. In January 2011, a workgroup consisting of ASCO and ONS members was convened to review feedback received since publication of the standards, to address interim changes in practice, and to modify the standards as needed. The most significant change to the standards is to extend their scope to the inpatient setting. This change reflects the conviction that the same standards for chemotherapy administration safety should apply in all settings. The proposed set of standards has been approved by the Board of Directors for both ASCO and ONS and has been posted for public comment. Comments were used as the basis for final editing of the revised standards. The workgroup recognizes that the safety of oral chemotherapy usage, nononcology medication reconciliation, and home chemotherapy administration are not adequately addressed in the original or revised standards. A separate process, cosponsored by ASCO and ONS, will address the development of safety standards for these areas.
2009 年 11 月,美国临床肿瘤学会(ASCO)与肿瘤护理学会(ONS)联合发布了一套 31 项关于成人癌症患者化疗安全的自愿性标准,这是一个高度结构化、多利益相关方参与的过程的最终结果。这些标准的制定明确是为了在肿瘤门诊环境中管理静脉和口服化疗药物时解决患者的安全问题。2011 年 1 月,由 ASCO 和 ONS 成员组成的工作组召开会议,审查标准发布后的反馈意见,解决实践中的临时变化,并根据需要修改标准。标准的最大变化是将其范围扩大到住院环境。这一变化反映了这样一种信念,即在所有环境中都应适用相同的化疗管理安全标准。该套标准已获得 ASCO 和 ONS 董事会的批准,并已公布供公众评论。意见被用作修订标准最终编辑的基础。工作组认识到,原始或修订标准没有充分涵盖口服化疗使用、非肿瘤药物调整和家庭化疗管理的安全性。ASCO 和 ONS 将联合开展一项单独的工作,以制定这些领域的安全标准。